130 related articles for article (PubMed ID: 17531523)
1. Molecular insight in cancer treatment and prevention.
Balducci L
Int J Biochem Cell Biol; 2007; 39(7-8):1329-36. PubMed ID: 17531523
[TBL] [Abstract][Full Text] [Related]
2. Cardiac glycosides as novel cancer therapeutic agents.
Newman RA; Yang P; Pawlus AD; Block KI
Mol Interv; 2008 Feb; 8(1):36-49. PubMed ID: 18332483
[TBL] [Abstract][Full Text] [Related]
3. Targeting multiple signal pathways by chemopreventive agents for cancer prevention and therapy.
Sarkar FH; Li YW
Acta Pharmacol Sin; 2007 Sep; 28(9):1305-15. PubMed ID: 17723164
[TBL] [Abstract][Full Text] [Related]
4. Single-agent and combination therapeutic strategies to inhibit hepatocyte growth factor/MET signaling in cancer.
Toschi L; Jänne PA
Clin Cancer Res; 2008 Oct; 14(19):5941-6. PubMed ID: 18829470
[TBL] [Abstract][Full Text] [Related]
5. Molecular targeting in the treatment of either advanced or metastatic bladder cancer or both according to the signalling pathways.
Wallerand H; Reiter RR; Ravaud A
Curr Opin Urol; 2008 Sep; 18(5):524-32. PubMed ID: 18670279
[TBL] [Abstract][Full Text] [Related]
6. Molecular oncology--perspectives in lung cancer.
Huber RM; Stratakis DF
Lung Cancer; 2004 Aug; 45 Suppl 2():S209-13. PubMed ID: 15552801
[TBL] [Abstract][Full Text] [Related]
7. Multitargeted therapy: can promiscuity be praised in an era of political correctness?
Jimeno A; Hidalgo M
Crit Rev Oncol Hematol; 2006 Aug; 59(2):150-8. PubMed ID: 16843676
[TBL] [Abstract][Full Text] [Related]
8. Cancer chemoprevention: scientific promise, clinical uncertainty.
Sporn MB; Liby KT
Nat Clin Pract Oncol; 2005 Oct; 2(10):518-25. PubMed ID: 16205771
[TBL] [Abstract][Full Text] [Related]
9. Fungal metabolites modulating NF-kappaB activity: an approach to cancer therapy and chemoprevention (review).
Petrova RD; Reznick AZ; Wasser SP; Denchev CM; Nevo E; Mahajna J
Oncol Rep; 2008 Feb; 19(2):299-308. PubMed ID: 18202775
[TBL] [Abstract][Full Text] [Related]
10. Targeted therapies: a new generation of cancer treatments.
Gerber DE
Am Fam Physician; 2008 Feb; 77(3):311-9. PubMed ID: 18297955
[TBL] [Abstract][Full Text] [Related]
11. Targeted therapy for oesophageal cancer: an overview.
Syrigos KN; Zalonis A; Kotteas E; Saif MW
Cancer Metastasis Rev; 2008 Jun; 27(2):273-88. PubMed ID: 18224295
[TBL] [Abstract][Full Text] [Related]
12. Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways.
Ramos S
Mol Nutr Food Res; 2008 May; 52(5):507-26. PubMed ID: 18435439
[TBL] [Abstract][Full Text] [Related]
13. Cancer chemopreventive agents-drugs for the 21st century?
Baer-Dubowska W
Acta Pol Pharm; 2006; 63(5):369-73. PubMed ID: 17357586
[TBL] [Abstract][Full Text] [Related]
14. Rational targeting of Notch signaling in cancer.
Rizzo P; Osipo C; Foreman K; Golde T; Osborne B; Miele L
Oncogene; 2008 Sep; 27(38):5124-31. PubMed ID: 18758481
[TBL] [Abstract][Full Text] [Related]
15. The role of nuclear factor kappaB in pancreatic cancer and the clinical applications of targeted therapy.
Holcomb B; Yip-Schneider M; Schmidt CM
Pancreas; 2008 Apr; 36(3):225-35. PubMed ID: 18362834
[TBL] [Abstract][Full Text] [Related]
16. The convergent development of molecular-targeted drugs for cancer treatment and prevention.
Lippman SM; Heymach JV
Clin Cancer Res; 2007 Jul; 13(14):4035-41. PubMed ID: 17634526
[TBL] [Abstract][Full Text] [Related]
17. The convergence of cancer prevention and therapy in early-phase clinical drug development.
Abbruzzese JL; Lippman SM
Cancer Cell; 2004 Oct; 6(4):321-6. PubMed ID: 15488755
[TBL] [Abstract][Full Text] [Related]
18. Translation of recent advances and discoveries in molecular biology and immunology in the diagnosis and treatment of pancreatic cancer.
Albo D; Farrow B; Berger DH
Surg Oncol Clin N Am; 2008 Apr; 17(2):357-76, ix. PubMed ID: 18375357
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
Liu H; Zang C; Emde A; Planas-Silva MD; Rosche M; Kühnl A; Schulz CO; Elstner E; Possinger K; Eucker J
Eur J Pharmacol; 2008 Sep; 591(1-3):43-51. PubMed ID: 18588872
[TBL] [Abstract][Full Text] [Related]
20. Targeted therapy of renal cell cancer.
Wysocki PJ; Zolnierek J; Szczylik C; Mackiewicz A
Curr Opin Investig Drugs; 2008 Jun; 9(6):570-5. PubMed ID: 18516756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
